Related Experiment Video
Updated: Feb 8, 2026

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches
Published on: October 13, 2022
Bi-allelic Mutations in Phe-tRNA Synthetase Associated with a Multi-system Pulmonary Disease Support
Zhiwen Xu1, Wing-Sze Lo2, David B Beck3
1IAS HKUST - Scripps R&D Laboratory, Institute for Advanced Study, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China; Pangu Biopharma, Edinburgh Tower, The Landmark, 15 Queen's Road Central, Hong Kong, China; aTyr Pharma, 3545 John Hopkins Court, Suite 250, San Diego, CA 92121, USA.
Recessive mutations in phenylalanine-tRNA synthetase (FARS) cause multi-system disease independent of protein synthesis. Loss-of-function FARS mutations highlight its crucial role in organ function beyond translation.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Transfer RNA (tRNA) synthetases are crucial for protein synthesis.
- Emerging research highlights their nuclear and extracellular functions beyond translation.
- Dominant gain-of-function mutations in tRNA synthetases are linked to diseases like Charcot-Marie-Tooth.
Purpose of the Study:
- To investigate the role of recessive loss-of-function mutations in tRNA synthetases.
- To identify the genetic basis and clinical manifestations of bi-allelic mutations in FARSB.
- To elucidate the disease mechanism associated with phenylalanine-tRNA synthetase (FARS) deficiency.
Main Methods:
- Clinical evaluation of five individuals from four families with a multi-system disease.
- Genetic analysis to identify bi-allelic mutations in the FARSB gene.
- Functional studies including assessment of exon skipping, frameshift, and protein synthesis activity.
Main Results:
- Identified five individuals with bi-allelic FARSB mutations, including a splice junction variant (SJV) and missense variants.
- Clinical presentation included interstitial lung disease, cerebral aneurysms, brain calcifications, and cirrhosis.
- Mutations led to noncatalytic activity and frameshift, but did not impair protein synthesis in affected individuals or carriers.
Conclusions:
- Bi-allelic loss-of-function mutations in FARSB cause a multi-system disease.
- The disease mechanism is independent of the canonical tRNA synthetase activity in protein translation.
- This study suggests a critical, non-translational role for phenylalanine-tRNA synthetase (FARS) in maintaining normal organ function.
Related Concept Videos
tRNA Activation
Mutations
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Termination of Translation
Multiple Allele Traits

